Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V T Devita

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|March 19, 1987
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's diseaseD W Blayney, D L Longo, R C Young, et al.
Annals of Internal Medicine|October 1, 1984
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group studyR F Bakemeier, J R Anderson, W Costello, et al.
Cancer|June 1, 1979
A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphomaH D Brereton, R C Young, D L Longo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatmentD L Longo, A Russo, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.
Cancer Clinical Trials|January 1, 1981
Animal toxicology for early clinical trials with anticancer agentsM Rozencweig, D D Von Hoff, M J Staquet, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.
Cancer Research|January 1, 1981
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancerR B Jones, J M Collins, C E Myers, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|March 19, 1987
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's diseaseD W Blayney, D L Longo, R C Young, et al.
Annals of Internal Medicine|October 1, 1984
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group studyR F Bakemeier, J R Anderson, W Costello, et al.
Cancer|June 1, 1979
A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphomaH D Brereton, R C Young, D L Longo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatmentD L Longo, A Russo, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and managementA Surbone, D L Longo, V T DeVita, et al.
Cancer Clinical Trials|January 1, 1981
Animal toxicology for early clinical trials with anticancer agentsM Rozencweig, D D Von Hoff, M J Staquet, et al.
Annals of Internal Medicine|May 1, 1980
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer InstituteV T DeVita, R M Simon, S M Hubbard, et al.
The New England Journal of Medicine|December 7, 1978
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapyR C Young, B A Chabner, S P Hubbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapyD L Longo, P L Duffey, E S Jaffe, et al.
Cancer Research|January 1, 1981
High-volume intraperitoneal chemotherapy with methotrexate in patients with cancerR B Jones, J M Collins, C E Myers, et al.
Pageof 13